26 May 2026

strategyland.uk

Imperial Brands PLC (IMB)

Rank #59 of 100 - Consumer Non-Cyclicals - UK Equities

Home/Stocks/Consumer Non-Cyclicals

Imperial Brands PLC

IMB.L·Consumer Non-Cyclicals·Market Cap £22.3b

Rank #59 of 100

Data from Excel Model · 100 Stocks Analysed

£28.27

-7.66% YTD

Target: £32.78(+15.9%)

52W: £26.99 - £33.41

Score Analysis

Imperial Brands PLC is ranked #59 out of 100 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

45/100

Average Score

Liquidity

Weak71/100

Valuation

Excellent19/100

Profitability

Weak67/100

Solvency

Fair53/100

Asset Efficiency

Fair50/100

Mkt Trading

Excellent25/100

Technical

Good31/100

1. Valuation

Score: 19/100

Is IMB undervalued compared to its peers and fair value metrics?

3/5

valuation criteria met

✓

FY26e P/E Ratio

8.6xRank 9/100

✓

FY27e P/E Ratio

7.9xRank 10/100

✗

Price-to-Book

5.28xRank 78/100

✗

Price-to-Tangible Book

N/ARank 101/100

✓

EV/EBITDA

8.1xRank 32/100

Key Valuation Metrics

Current P/E

13.5x

Price-to-Earnings

FY26e P/E

8.6x

Forward estimate

FY27e P/E

7.9x

Forward estimate

P/B Ratio

5.28x

Price-to-Book

P/TBV

N/A

Price-to-Tangible Book

EV/EBITDA

8.1x

Enterprise Value

FY26e EV/EBITDA

7.6x

Forward estimate

FY27e EV/EBITDA

7.6x

Forward estimate

Analyst Consensus Target

Current Price

£28.27

Consensus Target

£32.78

Potential

+15.9%

Target

Bloomberg Median Target: £33.50

2. Profitability

Score: 67/100

How profitable is IMB relative to its peers?

0/6

profitability criteria met

✗

TTM Profit Margin

9.7%Rank 41/100

–

Current ROE

40.3%

–

Current ROA

N/A

✗

FY26e EPS

3.67Rank 81/100

–

TTM EPS

3.56

–

Net Income Growth

N/A

Profit Margin

9.7%

ROE

40.3%

FY27e ROE

71.3%

ROA

N/A

Earnings Per Share

3. Financial Health

Score: 53/100

How strong is IMB's balance sheet and financial position?

0/4

solvency criteria met

–

Debt-to-Equity

184.0%

–

Interest Coverage

N/A

✗

Debt/EBITDA

Rank 46Rank 46/100

–

Altman Z-Score

2.03

Key Health Metrics

Quick Ratio

0.37

Below 1.0

Cash Ratio

0.74

Debt/Equity

184%

FCF Margin

3.5%

Altman Z-Score

2.03

Grey Zone

01.812.995+

4. Asset Efficiency

Score: 50/100

How efficiently does IMB deploy its assets and intellectual capital?

0/2

asset efficiency criteria met

–

Intangible/Asset

Intangible assets as a proportion of total assets — lower indicates more tangible, capital-efficient operations

N/A

–

R&D/Sales

Research & development spend relative to revenue — balanced R&D investment signals sustainable growth

N/A

Overall Asset Efficiency Rank

Rank within sector peers#50/100

Best (1)Worst (100)

What This Measures

Intangible/Asset — a lower ratio suggests the company's value is backed by tangible assets rather than goodwill or intangibles, reducing balance sheet risk.

R&D/Sales — captures the proportion of revenue reinvested into research and development, indicating innovation intensity and future growth investment.